RxDoctor Payments Data

Jason Roberts, MD

Gastroenterology · Indianapolis, INNPI 1871683979

Payments from drug & device makers

$4,889in general payments, 2019–2025

Across 257 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$496
  • Johnson & Johnson$366
  • Takeda Pharmaceuticals U.S.A., Inc.$310
  • Gilead$221
  • Nestle Healthcare Nutrition Inc.$175
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$4,875100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,889 in reported general payments places this provider in the 60th percentile of 323 gastroenterology providers in Indiana.

See all gastroenterology providers in Indiana

Medicare billing

Part B allowed, 2024
$206,947
Medicare patients
483
Services billed
5,952

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase40$124,196
Humira(Cf) PenAdalimumab13$84,226
XifaxanRifaximin19$67,069
LinzessLinaclotide18$21,209
Mesalamine ErMesalamine17$4,650
Colestipol Hcl41$3,435
Cholestyramine LightCholestyramine15$1,536
Omeprazole139$1,373
Dicyclomine Hcl44$982
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine38$928
Pantoprazole Sodium90$899
Esomeprazole Magnesium19$855
Famotidine40$644
LoperamideLoperamide Hcl22$588
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl35$428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$2,071$145,40558 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$496$67,06919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 323 gastroenterology providers in Indiana.

Other gastroenterology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →